Rapid Micro Biosystems
Provides automated microbial detection for pharmaceutical quality control.
Company facts
- Founded
- 2006
- Employees
- 230
- Headquarters
- United States
- CEO
- Robert Spignesi
- Type
- Public
- Listed
- NASDAQ: RPID
- Subsidiaries
- Rapid Micro Biosystems Europe GmbH
About
At the heart of Rapid Micro Biosystems is a commitment to redefining quality control in the life sciences industry. Our flagship product, the Growth Direct® System, revolutionizes traditional microbial testing methodologies by injecting unprecedented efficiency and accuracy into the process. Emphasizing automation, we have designed a system that reduces the time to results by eliminating 85% of the manual steps typically involved in microbial testing. This means that instead of waiting days or weeks, our clients can receive rapid results, allowing for quicker decision-making and enhanced productivity. We believe in empowering quality control laboratories by providing them with advanced tools that minimize the risks associated with human error and contamination. By digitizing and streamlining the entire testing process, we ensure compliance and data integrity, allowing our clients to focus on what they do best—delivering safe and effective products to the market. Our dedication to innovative solutions is paralleled by our commitment to customer service, as we strive to build lasting partnerships with our clients in the pharmaceutical and biotechnology sectors, ensuring their unique needs are met with expertise and dedication.